Regenerx Biopharm In Price Prediction

RGRXDelisted Stock  USD 0.0009  0.0001  12.50%   
At this time, the relative strength index (RSI) of Regenerx Biopharm's share price is approaching 43 indicating that the otc stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Regenerx Biopharm, making its price go up or down.

Oversold Vs Overbought

43

 
Oversold
 
Overbought
Regenerx Biopharm stock price prediction is an act of determining the future value of Regenerx Biopharm shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Regenerx Biopharm's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Regenerx Biopharm and does not consider all of the tangible or intangible factors available from Regenerx Biopharm's fundamental data. We analyze noise-free headlines and recent hype associated with Regenerx Biopharm In, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Regenerx Biopharm based on different types of headlines from major news networks to social media. The Regenerx stock price prediction module provides an analysis of price elasticity to changes in media outlook on Regenerx Biopharm over a specific investment horizon. Using Regenerx Biopharm hype-based prediction, you can estimate the value of Regenerx Biopharm In from the perspective of Regenerx Biopharm response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Regenerx Biopharm. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Regenerx Biopharm to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Regenerx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Regenerx Biopharm after-hype prediction price

    
  USD 0.001125  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Regenerx Biopharm's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.000.00090.00
Details
Naive
Forecast
LowNextHigh
0.060.060.06
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00080.00080.0008
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Regenerx Biopharm. Your research has to be compared to or analyzed against Regenerx Biopharm's peers to derive any actionable benefits. When done correctly, Regenerx Biopharm's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Regenerx Biopharm.

Regenerx Biopharm After-Hype Price Prediction Density Analysis

As far as predicting the price of Regenerx Biopharm at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Regenerx Biopharm or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Regenerx Biopharm, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Regenerx Biopharm Estimiated After-Hype Price Volatility

In the context of predicting Regenerx Biopharm's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Regenerx Biopharm's historical news coverage. Regenerx Biopharm's after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Regenerx Biopharm's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.0009
0
After-hype Price
0.00
Upside
Regenerx Biopharm is very steady at this time. Analysis and calculation of next after-hype price of Regenerx Biopharm is based on 3 months time horizon.

Regenerx Biopharm OTC Stock Price Prediction Analysis

Have you ever been surprised when a price of a OTC Stock such as Regenerx Biopharm is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Regenerx Biopharm backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Regenerx Biopharm, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
0 Events / Month
Within a week
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.0009
0
25.00 
0.00  
Notes

Regenerx Biopharm Hype Timeline

Regenerx Biopharm is at this time traded for 0.0009. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Regenerx is projected to increase in value after the next headline, with the price projected to jump to 0.001125 or above. The average volatility of media hype impact on the company the price is insignificant. The price jump on the next news is projected to be 25.0%, whereas the daily expected return is at this time at 0.0%. The volatility of related hype on Regenerx Biopharm is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company currently holds 1.14 M in liabilities. Regenerx Biopharm has a current ratio of 1.03, suggesting that it may have difficulties to pay its financial obligations when due. Debt can assist Regenerx Biopharm until it has trouble settling it off, either with new capital or with free cash flow. So, Regenerx Biopharm's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Regenerx Biopharm sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Regenerx to invest in growth at high rates of return. When we think about Regenerx Biopharm's use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next projected press release will be within a week.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Regenerx Biopharm Related Hype Analysis

Having access to credible news sources related to Regenerx Biopharm's direct competition is more important than ever and may enhance your ability to predict Regenerx Biopharm's future price movements. Getting to know how Regenerx Biopharm's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Regenerx Biopharm may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ARDSAridis Pharmaceuticals 0.00 0 per month 7.66  0.07  12.50 (12.50) 140.53 
MSSTFMindset Pharma 0.00 0 per month 1.64  0.14  5.26 (4.44) 21.64 
FBIOPFortress Biotech Pref 0.00 0 per month 3.37  0.02  3.71 (4.16) 22.88 
AWKNFAwakn Life Sciences 0.00 0 per month 9.12  0.10  22.22 (18.18) 61.22 
RGBPPRegen BioPharma 0.00 0 per month 0.00  0.09  35.59 (13.75) 91.46 
TSOITherapeutic Solutions International 0.00 0 per month 0.00 (0.08) 20.00 (16.67) 52.27 
PPCBDPropanc Biopharma 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
ACOGFAlpha Cognition 0.00 0 per month 0.00 (0.12) 7.41 (7.69) 20.63 
RGBPRegen BioPharma 0.00 0 per month 7.31  0.04  17.19 (12.31) 39.05 
ONPHOncology Pharma 0.00 0 per month 0.00 (0.14) 11.76 (13.64) 39.52 
KLDOKaleido Biosciences 0.00 0 per month 0.00  0.14  50.00 (25.00) 4,849 
NBIONascent Biotech 0.00 0 per month 9.27  0.0007  18.18 (18.18) 49.42 
PKTXProtokinetix 0.00 0 per month 8.95  0.03  17.14 (19.67) 56.34 
RSPIRespireRx Pharmaceuticals 0.00 0 per month 11.09  0.1  30.43 (21.57) 76.50 
SILOSilo Pharma 0.00 0 per month 2.91  0.15  4.90 (3.82) 18.88 
VGLSVg Life Sciences 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 

Regenerx Biopharm Additional Predictive Modules

Most predictive techniques to examine Regenerx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Regenerx using various technical indicators. When you analyze Regenerx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Regenerx Biopharm Predictive Indicators

The successful prediction of Regenerx Biopharm stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Regenerx Biopharm In, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Regenerx Biopharm based on analysis of Regenerx Biopharm hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Regenerx Biopharm's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Regenerx Biopharm's related companies.

Story Coverage note for Regenerx Biopharm

The number of cover stories for Regenerx Biopharm depends on current market conditions and Regenerx Biopharm's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Regenerx Biopharm is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Regenerx Biopharm's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Regenerx Biopharm Short Properties

Regenerx Biopharm's future price predictability will typically decrease when Regenerx Biopharm's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Regenerx Biopharm In often depends not only on the future outlook of the potential Regenerx Biopharm's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Regenerx Biopharm's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding143.5 M
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Consideration for investing in Regenerx OTC Stock

If you are still planning to invest in Regenerx Biopharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Regenerx Biopharm's history and understand the potential risks before investing.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data